Centers of Excellence
The Latest Research on Urology Imaging
The field of nuclear medicine has seen a resurgence in relevance especially in the area of prostate cancer imaging and therapy. Dr. Evan Yu adeptly summarizes the promising potential of PSMA radioligand therapies in his October 2018 post in the Clinical Trials section of UroToday. We look forward to seeing his future article regarding diagnostic trials evaluating various PSMA targeted agents.
Phillip J. Koo, MD is the Division Chief of Diagnostic Imaging at the Banner MD Anderson Cancer Center in Arizona. Prior to this, he was Chief of Nuclear Medicine and Associate Professor of Radiology at the University of Colorado School of Medicine. He is a diplomate of both the American Board of Radiology (ABR) and American Board of Nuclear Medicine and is the Chair of the Quality and Evidence Committee for the Society of Nuclear Medicine and Molecular Imaging.